CURRICULUM VITAE Alfred Bennett Jenson

CURRICULUM VITAE

Alfred Bennett Jenson, MD 3715 Glen Bluff Road, Louisville, KY 40222 PERSONAL DATA Phone (Work) 1-502-852-1114 (Home) 1-502-417-9894

EDUCATION B.A., Texas Christian University, Texas, 1957-61 (Cum Laude) M.S., Baylor University (College of Medicine), Texas, l964-66 M.D., Baylor College of Medicine, Texas, l961-66, with honor Internship, Department of Medicine, Baylor College of Medicine Affiliated Hospital Program, l966-67 Residency, Department of Pathology, Baylor College of Medicine Affiliated Hospital Program, l967-70 American Association of Immunology Summer Course, l970 Research Trainee, U.S. Public Health Service, l967-71 (Joe Melnick, Ph.D., Mentor) Postdoctoral Fellow of the National Multiple Sclerosis Society, l973-75 Basic Program Officials Guide to Contracting, l979 Sabbatical, National German Cancer Institute (DKFZ), Heidelberg, Germany, October- December, 1999.

POSITIONS  Chief Resident, Pathology, Ben Taub General Hospital, Houston, Texas, l969-70 (Harlan Spjut, MD, Pathology Chief of Staff).  Instructor, Department of Pathology, Baylor College of Medicine, l970-71.  Instructor in Pathology, Department of Optometry, University of Houston, Texas, l970-71  Comparative Pathologist, USAR, Veterinary Medicine Division, Veterinary Pathology Branch, Edgewood Arsenal, MD, l971-73.  Consultant, Cancer Cytology, Maryland State Department of Public Health and Hygiene, l972-73  Research Associate in Immunopathology, Scripps Clinic and Research Foundation, La Jolla, CA, 1973-75 (Frank Dixon, MD, Mentor).  Senior Medical Surgeon, USPHS, Laboratory of Oral Medicine, National Institutes of Dental Research, National Institutes of Health, MD, l975-80 (Abner Notkins, MD, Laboratory Chief).  Associate Professor, Department of Pathology, Georgetown University Schools of Medicine and Dentistry, l980-1989.  Vice-Chairman, Department of Pathology, Georgetown University Schools of Medicine and Dentistry, l983-85.  Acting Chairman, Department of Pathology, Georgetown University Schools of Medicine and Dentistry, 1985-89. Alfred Bennett Jenson, M.D. Curriculum Vitae

 Professor of Pathology, Department of Pathology, Georgetown University School  Medicine, 1989-June 30, 2000.  Adjunct Professor of Pathology, Georgetown University School of Medicine, from July 1, 2000.  Research Director, Cervical Cancer Research Institute, West Penn Hospital Foundation, Pittsburgh, PA, July 1, 2000-July 31, 2002.  Senior Scientist, Brown Cancer Center, University of Louisville Health Science Center,  Louisville, Kentucky, August 16, 2002-present.  Professor of Vaccinology, Brown Cancer Center, University of Louisville, Louisville, KY, 2002-present.  Senior Research Scientist, Division of Marine Mammal Research and Conservation, Harbor Branch Oceanograpic Institute, Inc, Ft. Pierce, FL, 2002-present.  Associate Member, Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY, until June 30, 2019  Associate Member, Department of Pharmacology and Toxicology, University of Louisville, KY, until June 30, 2018

LICENSURE Licensed in Maryland ,Washington, DC and Pennsylvania Board Certification in Anatomic Pathology, l971 Board Eligible in Immunopathology, 1975 Board Eligible in Clinical Pathology

AWARDS  Sheard-Sanford Award of the American Society of Clinical Pathology, l966.  Salvation Army Boy's Club Service Award, l967.  Phi Chi Sophomore Award for Excellence in Teaching, Baylor College of Medicine. 1970.  Army Commendation Medal, Vietnam, l973.  Nominee for Golden Apple Award for Excellence in Teaching, Georgetown University, l982, 1995, 1997, 1999, 2000.  Finalist, 2002 Health Care Hero Awards, Health Care Innovation and Research, Metropolitan Pittsburgh, March 7, 2002.  35th Dr. Sobodh Mitra M, Memorial Oration, Chittaranjan National Cancer Institute, Calcutta, 2004.  Mint Jubilee Co-Scientist of year award with Dr. Shin-je Ghim, Louisville, KY, 2006.  Louisville Metro Council Certificate of Distinguished Service, Louisville, KY, 2006.  Greater Louisville Inc., Fleur de Lis Award, 2006.  Co-Kentuckian of Year, Kentucky Monthly, 2006.  Kentucky Colonel Award: Governor Ernie Fletcher, State of Commonwealth Address, 2007; Governor Stephen Beshear, 2008.  Unbridled Spirit Award of the Commonwealth of Kentucky presented by Governor Ernie Fletcher, Cancer Survivor Day, James Graham Brown Cancer Center, 2007.

2 Alfred Bennett Jenson, M.D. Curriculum Vitae

 Manatee Conservation Award, Fish and Wild Service, Department of Interior, 2008.  Distinguished Professor Lectureship, 11th Annual Pathology of Mouse, Models of Human Disease, The Jackson Laboratory, Purdue University, Cornell University, University of Washington Medicine, Sep 2012.  Honorary Faculty, Georgia Aquarium Research Institute, Atlanta, GA, Feb 2014.  Distinguished Alumni Award, Texas Christian University, April 2014.

MEMBERSHIP IN SCIENTIFIC SOCIETIES  Sigma Xi, from l966.  International Academy of Pathology, from l970.  American Association of Pathologists, from l977.  College of American Pathology, From 1992.

COMMITTEES/STUDY SECTIONS/SITE VISITS (NON-UNIVERSITY)  Site Visit Team, Diabetes Research Training Centers, U. Michigan, U. Iowa Member, Intra- NIH Diabetes Mellitus Coordinating Committee, l976-85.  Chairman, Animal Care Committee, NIDR, NIH, l978-80.  International Committee on Taxonomy of Animal Viruses, Papovavirdae Study Group, from l980  Ad Hoc Member, Research Committee (Sexually Transmitted Disease Program Projects), NIAID, NIH, l982-84  Special Study Section (RFA-AM-05), Research on Autoimmunity Related to Endocrine Disease, March 11-13, l985  Site Visit Team, NINCDS, NIH, Program Project, Studies of Papillomas From the Upper Respiratory Tract, Long Island Jewish Medical Center, July 24-26, l985  Site Visit Team, NCI, NIH, HPV, Program Project, Clinical Significance and Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, April 1-4, l986.  Ad Hoc Member, Oral Biology and Medicine Study Section, Feb 1987, Feb 1988, 2000.  Special Study Section, NINCDS, NIH, Program Project, Studies of Papillomas From the Upper Respiratory Tract, Long Island Jewish Medical Center, 2000.  Special Study Sections, NCI, NIH, Epidemiology of HIV and Cancer, February 8-9, l988,  Bethesda, MD; February 12-13, 1989, Rockville, MD.  Site Visit Team, NCI, NIH, Hepatitis B Virus and Primary Hepatocellular Carcinoma, July 27-29, l988, Fox Chase Cancer Center, Philadelphia, PA.  Chairman, Role of Human Papillomavirus Detection Tests Committee, International Society for the Study of Vulvar Disease, from 1989.  Special Study Section, NCI, NIH, Epidemiology of Cancer in US Ethnic/Minority Population. May 13-15, 1991, Rockville, MD.  Invited Participant, Bethesda System Workshop for Cytology Nomenclature, 1988, 1991,  1992.  Honorary Member, Society of Canadian Colposcopists (From July 1995).  Member, International society of Vaccines, from 1997.

3 Alfred Bennett Jenson, M.D. Curriculum Vitae

 Reviewer, Viral Gene Expression and Replication in Papillomavirus-Associated Neoplasia (151/ONCO/28), Merit Review application for Department of Veterans Affairs, CA, February, 1998.  Special Study Section, NCI, Studies of Papillomas from the Upper Respiratory Tract, September 1998.  Scientific Committee and Faculty, 6th -17th International Papillomavirus Conference, 1986- 2000.  Invited Participant and Speaker, WHO, Technical meeting for review of the current status of development of prophylactic vaccines against human papillomavirus infection and associated diseases, Geneva, February 16-18, 1999.  International Papillomavirus Organizing Committee, 30th International Papillomavirus Conference, Malmo, Sweden, May 2009.

SELECTED PRESENTATIONS  Mary Lasker Conference Participant, American Cancer Society, Cancer and the Papillomavirus, Nov. 23-25, l985.  Invited Speaker, Ninth Peruvian Cancer Congress, Lima, Peru Nov. 26-28, l985.  Moderator, NCI Division of Cancer Etiology, Biological Carcinogenesis Branch. Workshop on the Transformation Mechanisms of Papillomavirus, Feb. 18-19, Bethesda, 1986.  Speaker, Ninth International Cytology Congress, Brussels, Belgium, May l986.  Invited Speaker, Fourteenth International Cancer Congress, Budapest, Hungary, August, l986.  Moderator and Speaker, Human Papillomaviruses and Squamous Carcinoma: Second International Conference, Oct. 27-29, l986; Third International Conference, October 24-27, l988; Fourth International Conference, September 16-19, 1990, Chicago, Illinois; Fifth International Conference, Oct. 25-28, 1992, Chicago, Illinois.  Invited Speaker, Colposcopy, Cervical and Vulvar Pathology and Gynecologic Laser Surgery Post-Graduate Course, Sarasota, Florida, March 23-29, l987, Feb.28-March 5, l988.  Invited speaker, Human Papillomaviral Infection and Lower Genital Tract Neoplasia Post- Graduate Course, The Regional Cancer Center-Saint Joseph's Hospital of Atlanta, Georgia, May 7-9, l987.  Chairman and speaker, Vistas in Immunopathology, XIV World Congress of Pathology, Papillomavirus and Cervical Cancer, June 21-26, Washington, DC, l987.  Co-organizer and speaker, Sixth International Papillomavirus Workshop, Georgetown University, Washington, DC, June. 14-18, l987.  Invited speaker, Antigenic Epitopes of Human papillomavirus, International Titisee Conference, HPV and Cervical Cancer, West Germany, Sept. l987.  Invited speaker, HPV-Related Lesions of Sites Other than the Genital Tract, College of American Pathology, HPV Workshop-Type Consensus Meeting, New York City, March 22- 23, l988.

4 Alfred Bennett Jenson, M.D. Curriculum Vitae

 Invited Speaker, The Use of Immunohistochemistry and DNA/RNA Hybridization Techniques for Diagnosis of Human Viral Diseases, College of American Pathology Course, October 25, l988, Las Vegas, Nevada,; March 12, l989, Chicago, Ill.  Invited Speaker, Detection of Viral Infections, AMA Biotechnology and Medicine Series, DNA Probes in the Practice of Medicine, San Diego, CA, November 4, l988 November 9, 1989.  Invited Speaker, Role of Human Papillomavirus in Premalignant and Malignant Lesions of the Urogenital Tract, Role of Nucleic Acid Probes in Disease Diagnosis. ASM Meetings, New Orleans, LA, May 15, l989.  Moderator and Invited Speaker, Human Papillomavirus Infections. The American Society for Colposcopy and Cervical Pathology, Washington, DC, October 21-22, 1989.  Plenary Speaker, Advances Toward the Development of a Broadly Cross-reactive Papillomavirus Vaccine Using Molecular Technology, American College of Veterinary Pathologists, Baltimore, MD, November 4, 1989.  Invited Faculty and Speaker, The Use of DNA Probes for the Diagnosis of HPV in "Diagnostic Pitfalls in Gynecologic Cytopathology" ASCP Workshop, Washington, DC, November 4, 1989.  Invited Speaker, Immune Response to Animal Papillomavirus, Animal Models of Human Viral Diseases: Relevance to Developmental Therapeutics, Burroughs-Welcome-UCLA Colloquium, Keystone, CO, March 31-April 5, 1990.  Moderator (Immune Response Session) and Invited Speaker, Ninth International Papillomavirus Workshop, Heidelberg, Germany, May 12-18, 1990.  Co-organizer and Moderator, Polymerase Chain Reaction-A Diagnostic Tool for the 1990s. October 11, 12, Washington, DC.  Invited Speaker, moderator and panel discussant, International Course on Cervical Cancer and Premalignant Lesions, October 12-14, 1991, Mexico City. VI. International Course on Cervical Cancer and Premalignant Lesions, October 14-16, 1992, Mexico City.  Invited Speaker, College American Pathology Conference XXIV, Molecular Pathology, HPV, August 19-22, Vancouver, BC, 1992.  Moderator, (Diagnosis and Therapeutic Response Section), Twelfth International Papillomavirus Workshop, Baltimore, MD, September 1993.  Panelist, PV Immunology, Workshop on Cervical Cancer, NCI, NIH, September 23-24,1993. Keynote Speaker (2), HPV and Cervical Cancer and HPV and Vaccines, Society of  Canadian Colposcopists, Calgary, Canada, June 1995.  Chairman, Session VII: Humoral Immunity, 16th International Papillomavirus Conference, Sienna, Italy, September 5th-12th, 1997.  Plenary Speaker, Human papillomavirus, 4th Asia-Pacific Congress of medical Virology, Seoul, Korea, November 4th-6th, 1997.  Invited participant and speaker, The National Cancer Institute’s Cancer Therapy Evaluation Program Strategy-Planning Meeting on Cervical Cancer and HPV Vaccines, Baltimore, MD, Sept.13-14. 1998.  Plenary Speaker, Human papillomavirus vaccines and Cervical Cancer, 17th International Papillomavirus Conference, Charleston, SC, January 9-15, 1999.

5 Alfred Bennett Jenson, M.D. Curriculum Vitae

 Invited participant, Walker’s Cay Colloquium on cancer vaccines and immunotherapy, Walker Cay, Cayman Islands, March 17-20, 1999.  Invited Speaker, Interagency/Oceanaria Manatee Working Group, Nov.8-9, 2000, Hawk’s Cay, Florida.  Invited Speaker, Prophylactic and Therapeutic HPV Vaccines, 16th Mid-Atlantic Gynecologic Oncology Society Meeting, October 18-20, 2001, Pittsburgh, PA.  Invited Speaker, 49th Annual Montagna Symposium on the Biology of Skin; emerging infections of the skin. Snowmass Colorado, Aug 12-16, 2000.  Invited Speaker, HPV testing for cervical cancer screening, Pre-conference International Symposium, AGOCICON, Calcutta, India, Dec. 13-16, 2001.  Invited Special DIGENE Speaker, Prophylactic and Therapeutic Vaccines for Cervical Cancer, The Real Perspective, AGOCICON, Calcutta, India, Dec. 13-16, 2001.  Invited Speaker, The Search for the HPV Vaccine, Update in Obstetrics and Gynecology III, The Western Pennsylvania Hospital and Department of Obstetrics and Gynecology, April 13, 2002.  Invited Speaker and Moderator, First Annual Cervical Cancer Conference, India. 2004.  Invited Speaker, 5th Dr. Subodh Mitra Memorial Oration, Chittaranjan National Cancer Institute, Calcutta, March 11 2004.  Invited Speaker, Chittarangan National Cancer Institute, Symposium on Recent trends in Cancer.  Research and Treatment, Golden Jubilee Celebration (1957-2007), Nov. 1-3. 2007.

COMMITTEES (UNIVERSITY) Infection Control Committee, GUMC, 1980-85. Institutional Review Board, GUMC, l981-83. Animal Welfare Committee, GUMC, l981-85. Chairman, Subcommittee of Infection Control Committee, Animals in the Hospital, l981-2000. Microbiology Chairman Search Committee, l981. Curriculum Committee, Georgetown University School of Dentistry, from l982. Science Committee, Lombardi Cancer Center, 1982-2000. Medical Center Committee on Honorary Degrees, l983. Clinical Laboratory Director Search Committee, l984. Medical Executive Faculty, l985-89. Dental Executive Faculty, l985-89. Executive Staff, from l985-89. Chairman, Animal Care and Use Committee, l987-91. Member, Committee on Patents, from l988-91. University Grievance Code Committee, 1990-2000. Immunology Task Force Committee, 1999-2000. RRF Building Committee, 1994-2000. Search Committee, Chief of Infectious Diseases, Department of Medicine, 1994. Ad Hoc Faculty Committee on Medical Center Finances, 1996. Research Committee, Georgetown University Medical School, 1996-2000. Scientific Advisor, Albert Sabin Vaccine Institute, 1997-2000. Instructor PBLs, University of Lousville Medical School, 1914-1915

6 Alfred Bennett Jenson, M.D. Curriculum Vitae

Lecture on Vaccines, Graduate School Oncology, University of Louisville Medical School, from 2006 DEPARTMENTAL RESPONSIBILITIES Director, Experimental Path. Graduate Program, 1981-85 Director, Dental General Pathology Course, l982-1987. Director, Electron Microscopy Unit, l980-84, 1987-88; 1989-present. Advisor, Immunocytochemistry Unit, l980-89 Director, Immunofluorescence Unit, from l982 Director, Residency Program, l988-1990 Co-Director, with Dr. Stan Geyer, 1990-92. Co-Director, with Dr. Adam Bagg, 1998-2000. Director, Autopsy Service, 1982-2000, intermittently. Experimental Pathology Graduate Committee, 1981-2000. Medical School Pathology Course Curriculum Committee,1993-2000. Executive Committee, Department of Pathology, 1997-1998.

MISCELLANEOUS Principle Investigator, NIDR, NIH - Papillomas of the Oral Cavity, l976-80 Project Officer, Contract on "Etiology of Oral Cavity Papillomas", l979-80 Project Officer, Contract on "Search for Diabetogenic Viruses", l979-80 President, Society of Fellows, Scripps Clinic and Research Foundation, 1974-75 Ad Hoc Pathologist, American Type Culture Collection, from l981 Mayor's Commission on Forensic Pathology, Washington DC, 1989-2000. Inspector of Laboratories, CAP, from 1994- (Sibley Hospital, Fall 1996; Providence Hospital Spring 1998; Greater Southeast Hospital, Spring 2000).

EDITORIAL BOARDS Survey of Immunologic Research- Immunopathology Editor, from l981 Pathobiology, Editorial Board from l982 Immunology News Letter, Editorial Board, 1992-97 Experimental and Molecular Pathology, Editorial Board, from 2000. GRANTS, CONTRACTS

PAST BRL Contract for development of HPV diagnostics, 1984-85, total direct costs 38,400, PI. CDC Contract 200-84-0774 for development of HPV diagnostics, 1987, total direct costs, $125,843, PI. NIH Grant for International Papillomavirus Workshop, 1987, $10,000, PI with Wayne Lancaster CDC Subcontract with Mt Sinai Hospital, Papillomavirus infection in the lower genital tract, total direct costs $16,958, PI. Malignant Squamous Lesions of the Oral Cavity and Lower Respiratory Tracts, CTR Special Project, January 1, l982-August 30,l991, total costs $1,000,000 PI. Antigen and Genome Detection of Arenavirus, Bunyavirus, and Filovirus Infections, Department of Defense, September 12, 1988-September 12, l991, total direct costs $494,000, PI.

7 Alfred Bennett Jenson, M.D. Curriculum Vitae

Antigenic Determinants of the Papillomavirus L1 Capsid Protein (RO1 CA50182-01). NCI, NIH, Sept. 30, l989-1993, total direct costs $227,700, PI. HPV Vaccine Development, Medimmune Inc., total direct costs $225,000, PI, 1992-1997. Anonymous donor, total direct costs $46,000, PI, 1991. CDC Subcontract, HPV Serological studies in HIV-infected women, total costs $150,000, PI, 1995-97. R01-DE11245, T Cell Responses to Oral PV Vaccines: A Canine Model, total direct costs $600,000, PI, September 27, 1995-June 30, 2000.

PRESENT Phillip Morris, Inc. Agripharmaceuticals for production of a papillomavirus vaccine in Tobacco Plants, total, Costs $70,000, PI, 2002-. Snow leopard vaccine grant, Seattle zoo, $5,500 total, PI Marshall Farm COPV Vaccine Fund; Co-PI with Shin-je Ghim, $25,000, 2002- PI, Kentucky Cancer Experimental Therapeutics Program. Office for the New Economy Cabinet Novel Immunotherapeutic through plant biotechnology” $500,000 for 2004- PI, Development of formalin-inactivated papillomavirus L2 vaccine. Kentucky Science and Technology Corporation Award, KSEF-602-RDE-006. $15,000, 2004-2005. PI, Clinical & Translational Science Basic Grant Awardee, U of L, $47,500.

PATENTS Patented with Richard Schlegel and Shin-je Ghim, US Patent, Application Serial No 8/216,506, Papillomavirus Vaccines, approved by U. S. Patent Court 2005 (Cross-licensed between GSK and Merck, 2006). Patent Pending with Richard Schlegel, Papillomavirus Serology Patented with Richard Schlegel and Shin-je Ghim. Canine oral papillomavirus Patented with Richard Schlegel and Shin-je Ghim, Formalin-inactivated L1 Protein Vaccine. Exclusive Mab License agreement with BABCO with Richard Schlegel. Patent Pending ULRF 07041 - U. S. Provisional Patent Application Serial No. 60/888,873 – Tobacco plant derived papillomavirus vaccine and related methods, U of L Patent pending ULRF 07052 (Jenson, Ghim, et al) - Divalent EcPV and BPV Vaccine, U of L Patent Ref. 05043 - U. S. Patent 7,445,786- Diagnosing and protecting against tursiops truncates papillomavirus, U of L Patent Ref. 07015 (Chaires, Jenson, Garbett) - Proteomic profiling method useful for condition diagnosis, U of L Patent pending ULRF (Ghim, Jenson, Trent)

PUBLICATIONS (PEER REVIEWED-#180)

1. Rabin, ER, Hassan, SA, Jenson, AB, and Melnick, JL. Coxsackievirus B3 myocarditis in mice: An electron microscopic, immunofluorescence and virus assay study. Amer. J. Pathol. 44:775-97, 1964. 2. Jenson, AB, Rabin, ER, Phillips, CA, and Melnick, JL: Reovirus encephalitis in newborn mice: An electron microscopic and virus assay study. Amer. J. Pathol. 47:223-39, l965.

8 Alfred Bennett Jenson, M.D. Curriculum Vitae

3. Rabin, ER, Phillips, CA, Jenson, AB, and Melnick, JL: Vaccinia virus myocarditis in mice: An electron microscopic study. Exp Mol Pathol. 4:98-111, 1965. 4. Jenson AB, Rabin ER, Bentinck D, and Rapp F: Reovirus viremia in newborn mice: An electron microscopic, immunofluorescent and virus assay study. Am J Pathol. 49:1171-83, 1966. 5. Jenson AB, Rabin ER, Wende RD, and Melnick JL. A comparative light and electron microscopic study of rabies and Hart Park virus encephalitis. Exp Mol Pathol. 7:1-10, 1967. 6. Rabin ER and Jenson AB. Electron microscopic studies of animal viruses with emphasis on in vivo infections. Prog Med Virol. 9:392-450, 1967. 7. Jenson AB, Fred HL. Toothpick pleurisy. JAMA 203:988, l968. 8. Kalus M, Jenson AB, Rabin ER, and Melnick JL. Marmoset liver organ culture infected with herpes virus. Exp Mol Pathol. 8:388-93, 1968. 9. Melnick JL, Rabin ER, and Jenson AB. Intracellular herpes virus aggregate in the form of a pentagonal pyramidal crystal-like structure. J Virol 2:78-80, 1968. 10. Murphy FA, Whitfield SG, Coleman PH, Calisher CH, Rabin ER, Jenson AB, Melnick JL, Edwards MR. and Whitney E. California group arboviruses: electron microscopic studies. Exp Mol Pathol 9:44-56, 1968. 11. Rabin ER, Jenson AB, and Melnick JL. Herpes simplex virus in mice: electron microscopy of neural spread. Science 162:126-7, 1968. 12. Rabin ER, Jenson AB, Phillips CA, and Melnick JL. Herpes simplex virus hepatitis in mice. An electron microscopic study. Exp Mol Pathol 8:34-48,1968. 13. Jenson AB, and Fechner RE. Ultrastructure of an intermediate Sertoli-Leydig cell tumor. A histogenetic misnomer. Lab Invest 21:527-35, 1969. 14. Jenson AB, Rabin ER, Bentinck DC, Melnick JL. Rabiesvirus neuronitis. J Virol 3:265-9, 1969. 15. Jenson AB, McCombs RM, and Melnick JL. Au-antigen particles. Lancet 2:311, 1970. 16. Jenson AB, McCombs RM, Sakurada N, and Melnick JL. Organ cultures inoculated with serum from a hepatitis patient with Au antigenemia. Exp Mol Pathol 13:217-30, 1970. 17. Askew JB Jr, Bentinck DC, Jenson AB, and Fechner, RA.. Epithelial and myoepithelial oncocytes. Ultrastructural study of a salivary gland oncocytoma. Arch Otolaryngol 93:46- 54, 1971. 18. Jenson AB, Melnick JL, Boyd KR, and Wende RD. Rapid identification of an arbovirus by observation on its morphogenesis in the electron microscope. J Infect Dis 123:551-4, 1971. 19. Jensen AB, Spjut HJ, Smith MN, and Rapp F. Intracellular branched tubular structures in osteosarcoma. An ultrastructural and serological study. Cancer 27:1440-8, 1971. 20. Acker D, Jenson AB, Tenn GK. Abdominal pregnancy with intrauterine device in situ. Obstet Gynecol 42:36-9, 1973. 21. Renne RA, McLaughlin R, and Jenson AB. Measles virus-associated endometritis, cervicitis, and abortion in a rhesus monkey. J Am Vet Med Assoc 163:639-41, l973. 22. Jenson AB, Groff DE, McConahey PJ, and Dixon FJ. Transmission of murine leukemia virus (Scripps) from parent to progeny mice: a comparison of assay systems. J Natl Cancer Inst 57:421-4, 1976.

9 Alfred Bennett Jenson, M.D. Curriculum Vitae

23. Jenson AB, Groff DE, McConahey PJ, and Dixon FJ. Transmission of murine leukemia virus (Scripps) from parent to progeny mice as determined by p30 antigenemia. Cancer Res 36:1228-32, 1976. 24. Onodera T., Jenson AB, Yoon JW, and Notkins AL. Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science 201:529-31, 1978. 25. Prince GA, Jenson AB, Billups LC, and Notkins AL. Infection of human pancreatic beta cell cultures with mumps virus. Nature 271:158-61, 1978. 26. Prince GA, Jenson AB, Horswood RL, Camargo E, and Chanock RM. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol 93:771-91, l978. 27. Yoon JW, Onodera T, Jenson AB, and Notkins AL. Virus-induced diabetes mellitus. XI. Replication of Coxsackie B3 virus in human pancreatic beta cell cultures. Diabetes 27:778- 81, 1978. 28. Dobersen MJ, Bell AM, Jenson AB, Notkins AL, Ginsberg-Fellner F. Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen. Lancet 2:1078, l979. 29. Notkins AL, Yoon J, Onodera T, and Jenson AB. Virus-induced diabetes mellitus: infection of mice with variants of encephalomyocarditis virus, coxsackievirus B4, and reovirus type 3. Adv Exp Med Biol 119:137-46, 1979. 30. Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet-cell damage in children with fatal viral infections. Lancet 2:354-8, 1980. 31. Jenson AB, Rosenthal JD, Olson C, Pass F, Lancaster WD, Shah K. Immunologic relatedness of papillomaviruses from different species. J Natl Cancer Inst 64:495-500, l980. 32. Lack EE, Jenson AB, Smith HG, Healy GB, Pass F, and Vawter GF. Immunoperoxidase localization of human papillomavirus in laryngeal papillomas. Intervirology. 14:148-54, 1980. 33. Lack EE, Vawter GF, Smith HG, Healy GB, Lancaster WD, and Jenson AB. Immunohistochemical localization of human papillomavirus in squamous papillomas of the larynx. Lancet 2:592, l980. 34. Shah KH, Lewis MG, Jenson AB, Kurman RJ, Lancaster WD. Papillomavirus and cervical dysplasia. Lancet 2:1190, 1980 35. Cramer SF, Mandel MA, Hauler R, Lever WF, and Jenson AB. Squamous cell carcinoma arising in a linear epidermal nevus. Arch Dermatol 117:222-4, 1981. 36. Kurman RJ. Shah KH, Lancaster WD, and Jenson AB. Immunoperoxidase localization of papillomavirus antigens in human cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol 140:931-5, 1981. 37. Lancaster WD, and Jenson AB. Evidence of papillomavirus genus-specific antigens and DNA in laryngeal papilloma. Intervirology. 15:204-12, 1981. 38. Onodera T, Toniolo A, Ray UR, Jenson AB, Knazek RA, and Notkins AL. Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med 153:1457-73, 1981. 39. Patterson K, Chandra RS, and Jenson AB. Congenital rubella, insulitis and diabetes mellitus in an infant. Lancet 1:1048-49, l981. 40. Yoon JW, Selvaggio S, Onodera T, Wheeler J, and Jenson AB. Infection of cultured human pancreatic B cells with reovirus type 3. Diabetologia 20:462-7, 1981.

10 Alfred Bennett Jenson, M.D. Curriculum Vitae

41. Jenson AB and Dobersen MJ. Etiopathology of diabetes mellitus. Perspect Pediatr Pathol 7:167-84, 1982. 42. Jenson AB, Lancaster WD, Hartmann DP, and Shaffer EL Jr. Frequency and distribution of papillomavirus structural antigens in verrucae, multiple papillomas and condylomata of the oral cavity. Am. J. Pathol. 107:212-8, 1982. 43. Jenson AB, Sommer S, Payling-Wright C, Pass F, Link CC Jr, and Lancaster WD. Human papillomavirus. Frequency and distribution in plantar and common warts. Lab Invest 47:491-7, 1982. 44. Kurman RJ, Sanz LE, Jenson AB, Perry S, and Lancaster WD. Papillomavirus infection of the cervix I. Correlation of histology with viral structural antigens and DNA sequences. Int J Gynecol Pathol 1:17-28, 1982. 45. Dean P, Lancaster WD, Chun B, and Jenson AB. Human papillomavirus structural antigens in squamous papillomas of the male urethra. J Urol 129:873-5, 1983. 46. Gaydos DS, Goldin H, Jenson B, Gersten D, Boedeker B, Bartz C, and Preuss HG. Partial characterization of a renotropic factor. Ren Physiol 6:139-44, 1983. 47. Kurman RJ, Jenson AB, Lancaster WD. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins. Am J Surg Pathol 7:39-52, 1983. 48. Lancaster WD, Kurman RJ, Sanz LE, Perry S, Jenson AB. Human papillomavirus: detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix. Intervirology. 20:202-12, 1983. 49. Lass JH, Grove AS, Papale JJ, Albert DM, Jenson AB, Lancaster WD. Detection of human papillomavirus DNA sequences in conjunctival papilloma. Am J Opthalmol 96:670-4, 1983. 50. Lass JH, Jenson AB, Papale JJ, and Albert DM. Papillomavirus in human conjunctival papillomas. Am J Opthalmol 95:364-8, 1983. 51. Murphy WM, Fu YS, Lancaster WD, and Jenson AB. Papillomavirus structural antigens in condyloma acuminatum of the male urethra. J Urol 130:84-5,1983. 52. Jenson AB and Rosenberg HS. Multiple viruses in diabetes mellitus. Prog Med Virol 29:197-217, 1984. 53. Kurman RJ, Jenson AB and Lancaster WD. Papillomavirus infection and squamous neoplasia of the cervix. Pathol Res Pract 179:24-30, 1984. 54. Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, and Schulman JD. Familial premature ovarian failure. Am J Human Genet 36:1341-8, 1984. 55. Rams TE, Keyes PH, and Jenson AB : "Action de sel inorganiques, de la chloramine-T, et de l'acide citrique sur la plaque bacterienne sous-ginvivale." Odontologia 5:37-47, l984. 56. Rams TE, Keyes PH, and Jenson AB. Morphological effects of inorganic salts, chloramine-T, and citric acid on subgingival plaque bacteria. Quintessence Int 15:835-44, l984. 57. Warhol MJ, Pinkus GS, Rice RH, El-Tawil GH, Lancaster WD, Jenson AB, Kurman RJ. Papillomavirus infection of the cervix. III. Relationship of the presence of viral structural proteins to the expression of involucrin. Int J Gynecol Pathol 3:71-81, 1984. 58. Gabriel SA, Jenson AB, Hartmann D, and Bottomley WK. Lichen planus: possible mechanisms of pathogenesis. J Oral Med 40:56-9, l985.

11 Alfred Bennett Jenson, M.D. Curriculum Vitae

59. Gorra JB, Lancaster WD, Kurman RJ, and Jenson AB. Bovine papillomavirus type 1 monoclonal antibodies. J Natl Cancer Inst. 75:121-5, l985. 60. Jenson AB, Kurman RJ, and Lancaster WD. Detection of papillomavirus common antigens in lesions of skin and mucosa. Clin Dermatol 3:56-63. 61. Jenson AB, Lim LY, and Lancaster WD. Role of papilloma virus in proliferative squamous lesions. Surv Synth Pathol Res 4:8-13, 1985 62. Strauss M and Jenson AB. Human papillomavirus in various lesions of the head and neck. Otolaryngol Head Neck Surg 93:342-6, 1985. 63. Brescia RJ, Jenson AB, Lancaster WD, Kurman RJ. The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix. Human Pathol. 17:552-59, l986. 64. Lancaster WD, Castellano C, Santos C., Delgado G, Kurman RJ, Jenson AB. Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol 154:115-9, l986. 65. Lorincz AT, Temple GF, Patterson JA, Jenson AB, Kurman RJ, Lancaster WD. Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol 68:508-12, 1986. 66. Nakai Y, Lancaster WD, Lim LY, and Jenson AB. Monoclonal antibodies to genus-and type-specific papillomavirus structural antigens. Intervirology 25:30-7, l986. 67 Prince GA, Jenson AB, Hemming VG, Murphy BR, Walsh EE, Horswood RL, and Chanock RM. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J Virol. 57:721-28, l986. 68. Rando RF, Sedlacek TV, Hunt J, Jenson AB, Kurman RJ, Lancaster WD. Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus. Obstet. Gynecol. 67(3 Suppl): 70S-75S, l986. 69. Cowsert LM, Lake P, and Jenson AB. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. J Natl Cancer Inst 79:1053-57, 1987. 70. Jenson AB, Kurman RJ, and Lancaster WD. Tissue effects of and host response to human papillomavirus infection. Obstet Gynecol Clin North Am 14:397-406, 1987 71. Lancaster WD and Jenson AB. Human papillomavirus infection and anogenital neoplasia: speculations for the future. Obstet Gynecol Clin North Am 14:601-9, 1987. 72. Lancaster WD and Jenson AB. Natural history of human papillomavirus infection of the anogenital tract. Cancer Metastasis Rev 6:653-64, 1987. 73. Lass JH, Foster CS, Grove AS, Rubenfeld M, Lusk RP, Jenson AB, and Lancaster WD. Interferon-alpha therapy of recurrent conjunctival papillomas. Am J Opthalmol 103(3 Pt 1): 294-301, 1987. 74. Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 79:671-77, l987. 75. Nakai Y., Lancaster WD and Jenson AB. Purification of papillomavirus structural polypeptides from papillomas by immunoaffinity chromatography. J Gen Virol 68:1891- 96, 1987.

12 Alfred Bennett Jenson, M.D. Curriculum Vitae

76. Reid R, Greenberg M, Jenson AB, Husain M, Willett J, Daoud Y, Temple G, Stanhope CR, Sherman AI, Phibbs GD, and Lorincz A. Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol 156:212-22, l987. 77. Barnes W, Delgado G, Kurman RJ, Petrilli ES, Smith DM, Ahamed S, Lorincz AT, Temple GF, Jenson AB, and Lancaster WD. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 29(3):267-73, l988. 78. Cowsert LM, Pilacinski WP, and Jenson AB. Identification of the bovine papillomavirus L1 gene product using monoclonal antibodies. Virol. 165:613-15, 1988. 79. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, and Lorincz AT. Analysis of individual papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 159:293-96, l988. 80. Jenson AB, Lim LY, and Singer E. Comparison of human papillomavirus type 1 serotyping by monoclonal antibodies with genotyping by in situ hybridization of plantar warts. J Cutan Pathol 16:54-9, l989. 81. Jin XW, Cowsert LM, Pilacinski WP, and Jenson AB. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 by monoclonal antibodies. J Gen Virol 70(Pt 5):1133-40, 1989. 82. Murphy BR, Sotniknov A, Paradiso PR, Hildreth SW, Jenson AB, Baggs RB, Lawrence L, Zubak JJ, Chanock RM, Beeler JA, et al. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine 7:533-40, 1989 83. O'Brien WM, Jenson AB, Lancaster WD, and Maxted WC. Human papillomavirus typing of penile condyloma. J Urol 141:863-65, 1989. 84. Willett GD, Kurman RJ, Reid R, Greenberg M, Jenson AB, Lorincz AT. Correlation of the histologic appearance of intraepithelial neoplasia of the cervix with human papillomavirus types. Emphasis on low grade lesions including so-called flat condyloma. Int J Gynecol Pathol 8:18-25, 1989. 85. Luka J, Deeb ZE, Hartmann DP, Jenson AB, and GR Pearson: Detection of antigens associated with Epstein-Barr virus replication in extracts from biopsy specimens of nasopharyngeal carcinomas. JNCI 80:1164-67, l988. 86. Prince GA, Porter DD, Jenson AB, Horswood, RL, Chanock RM, Ginsberg HS. Pathogenesis of adenovirus type 5 pneumonia in the cotton rat (Sigmodon hispidus). J. Virol. 67:101-11, 1993. 87. Jenson AB. Genetic probes in the detection of human papillomavirus. Modern Med. 57:50-6, 1989. 88. Barnes W, Woodworth G, Waggoner S, Stoler M, Jenson AB, Delgado, G, and DiPaolo J. Rapid dysplastic transformation of human genital cells by human papillomavirus type 18. Gynecol Oncol 38:343-46, 1990. 89. Jenson AB. Interpretation of HPV-testing. Pathobiology 58:211, 1990. 90. Jin XW, Cowsert L, Marshall D, Reed D, Pilacinski, W, Lim, LY, and Jenson, AB. Bovine serological response to a recombinant BPV-1 major capsid protein vaccine. Intervirology. 31;345-54, 1990.

13 Alfred Bennett Jenson, M.D. Curriculum Vitae

91. Lewandowski G, Delgado G, Holloway RW, Farrell M, Jenson AB, Lancaster WD. The use of in situ hybridization to show human papillomavirus deoxyribonucleic acid in metastatic cancer cells within lymph nodes. Am J Obstet Gynecol 163:1333-37, 1990. 92. Lim PS, Jenson AB, Cowsert L, Nakai Y, Lim LY, Jin XW, Sundberg JP. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J Infect Dis 162:1263- 69, 1990. 93. Ghim S, Christensen ND, Kreider JW, and Jenson AB. Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int J Cancer 49; 285-89, 1991. 94. Holloway RW, Farrell MP, Castellano C, Barnes WA, Lewandowski G, Jenson B, Santos C, Ramierez G, and Delgado G. Identification of human papillomavirus type 16 in primary and recurrent cervical cancer following radiation therapy. Gynecol Oncol 41:123-8, 1991. 95. Jenson AB, Kurman RJ, and Lancaster WD. Tissue effects of and host response to human papillomavirus infection. Dermatol Clin 9:203-9, 1991. 96. Jenson AB, Lim P, Ghim S, Cowsert L, Olson C, Lim LY, Farquhar C., and Pilacinski W. Identification of linear epitopes of the BPV-1 L1 protein recognized by sera of infected or immunized animals. Pathobiology 59;396-403, 1991. 97. Lancaster WD and Jenson AB. Human papillomavirus infection and neoplasia. Speculations for the future. Dermatol Clin 9:371-6, 1991. 98. Reid R, Greenberg MD, Lorincz A, Jenson AB, Laverty CR, Husain M, Daoud Y, Zado B, White T, Cantor D, and et al. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 164:1461-9; discussion 1469-71, 1991. 99. Ghim SJ, Jenson AB, and Schlegel R. HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology 190: 548-52, 1992. 100. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, and Kurman RJ. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol. 79:328-37, 1992. 101. Connolly BM, Jenson AB, Peters CJ, Geyer SJ, Barth JF, and McPherson RA. Pathogenesis of Pichinde virus infection in strain 13 guinea pigs: an Immunocytochemical, virologic, and clinical chemistry study. Am J Trop Med Hyg 49:10-24, 1993. 102. Ghim SJ and Jenson AB. Identification of conformational epitopes of the BPV-1 capsid recognized by competitive inhibition of sera from infected or immunized animals. Pathobiology. 61:138-44, 1993. 103. Jochmus I, Durst M, Reid R, Altmann A, Bijward KE, Gissmann L, and Jenson AB. Major histocompatibility complex and human papillomavirus type 16 E7 expression in high grade vulvar lesions. Human Pathol. 24:519-24, 1993. 104. Prince GA, Porter DD, Jenson AB, Horswood RL, Chanock RM, and Ginsberg HS. Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol 67:101-11, 1993. 105. Bell JA, Sundberg JP, Ghim SJ, Newsome J, Jenson AB, Schlegel R. A formalin- inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology. 62:194-98, 1994.

14 Alfred Bennett Jenson, M.D. Curriculum Vitae

106. Christensen ND, Kirnbauer R, Schiller JT, Ghim SJ, Schlegel R, Jenson AB, Kreider JW. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology. 205:329-35, 1994. 107. Delius H, Van Ranst MA, Jenson AB, zur Hausen H, Sundberg, JP. Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology. 204:447-52, 1994. 108. Hines JF, Ghim SJ, Christensen ND, Kreider JW, Barnes WA, Schlegel R, and Jenson AB. The expressed L1 proteins of HPV-1, HPV-6 and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and non-neutralizing antibodies. Pathobiology. 62:165-71, 1994. 109. Hines JF, Ghim SJ, Christensen ND, Kreider JW, Barnes WA, Schlegel R, and Jenson AB. Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination. Gynecol Oncol 55:13-20, 1994. 110. Roden RB, Kirnbauer R., Jenson AB, Lowy DR, and Schiller JT. Interaction of papillomaviruses with the cell surface. J Virol. 68:7260-6,1994. 111. Sundberg JP, Smith EK, Herron AJ, Jenson AB, Burk RD, and Van Ranst M. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog. Vet Pathol 31:183-87, 1994. 112. Hamir AN, Mose, G, Jenson AB, Sundberg JP, Hanlon C and Rupprecht, CE. Papillomavirus infection in raccoons (Procyon lotor). J Vet Diagn Invest 7:549-51, 1995. 113. Hines JF, Ghim S, Schlegel R. and Jenson AB. Prospects for a vaccine against human papillomavirus. Obstet & Gynecol 86:860-6, 1995. 114. Hines JF, Jenson AB, and Barnes WA. Human papillomaviruses: their clinical significance in the management of cervical carcinoma. Oncology 9:279-85; discussion 286- 8, 291, 1995. 115. Muller M, Gissmann L, Cristiano RJ, Sun XY, Frazer IH, Jenson AB, Alonso, A, Zentgraf H., and Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol 69:948-54, 1995. 116. Suzich JA, Ghim SJ, Palmer-Hill FJ, White WI, Tamura JK, Bell JA, Newsome JA, Jenson AB, Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92:11553-57, 1995. 117. Ferenczy A and Jenson AB. Tissue effects and host response. The key to the rational triage of cervical neoplasia. Obstet Gynecol Clin North Am 23:759-82, 1996. 118. Ghim SJ, Young R, and Jenson AB. Antigenicity of bovine papillomavirus type 1 (BPV- 1) L1 virus-like particles compared with that of intact BPV-1 virions. J Gen Virol 77:183- 88, 1996. 119. Hines JF, Ghim SJ, and Jenson AB. Human papillomavirus infection. Bmj 312:522-3, 1996. 120. Sundberg JP, Montali RJ, Bush M, O’Brien SJ, Jenson AB, Burk RD. Van Ranst M. Papillomavirus associated focal oral hyperplasia in asian lions (Panthera leo persica). J Zoo Wildlife Medicine, 27:61-70, 1996.

15 Alfred Bennett Jenson, M.D. Curriculum Vitae

121 Jenson AB, Jenson MC, Cowsert L, Ghim SJ, and Sundberg JP. Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes. Immunol Res 16:115-9, 1997. 122. Sundberg JP, France M, Boggess D, Sundberg BA, Jenson AB, Beamer WG and Shultz LD. Development and progression of psoriasiform dermatitis and systemic lesions in the flaky skin (fsn) mouse mutant. Pathobiology 65:271-86, 1997. 123. Chen Y., Ghim SJ, Jenson AB, and Schlegel R. Mutant canine oral papillomavirus L1 capsid proteins that form virus-like particles but lack native conformational epitopes. J Gen Virol 79:2137-46, 1998. 124. Hines JF, Ghim SJ, and Jenson AB. Prospects for human papillomavirus vaccine development: emerging HPV vaccines. Curr Opin Obstet Gynecol 10:15-9, 1998. 125. Stark S., Petridis AK, Ghim SJ, Jenson AB, Bouwes Bavinck JN, Gross G. Stockfleth E, Fuchs PG,and Pfister H. Prevalence of antibodies against virus- like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 111:696-701, 1998. 126. Sundberg JP, Schlegel R, and Jenson AB, Mucosotropic papillomavirus infections. Lab Anim Sci 48:240-2, 1998. 126. White WI, Wilson SD, Palmer-Hill FJ, Woods RM, Ghim SJ, Hewitt LA, Goldman DM, Burke SJ, Jenson AB, Koenig S, Suzich JA. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol 73:4882-9, 1999. 128. Ghim SJ, Newsome J, Bell J, Sundberg JP Schlegel R, Jenson AB. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus. Exp Mol Pathol 68:147-151, 2000. 129. Sundberg JP, Van Ranst M, Montali R, Homer BL, Miller WH, Rowland PH, Scott DW, England JJ, Dunstan RW, Mikaelian I, and Jenson AB. Feline papillomas and Papillomaviruses. Vet Pathol 37:1-10, 2000. 130. Bossart, GD,. Ewing RY, Lowe M., Sweat M, Decker, Walsh, CJ, Ghim S-J, and Jenson, AB. Viral Papillomatosis in Florida Manatees (Trichechus manatus latirostris). Exp Mol Pathol. 72:37-48, 2002.

131. Tachezy, R. Duson, G, Rector, A, Jenson, AB. Sundberg, JP and Van Ranst, M. Cloning and genomic characterization of Felis Domesticus Papillomavirus Type 1. Virology 301, 3- 3-321, 2002. 132. Jenson, AB, Geyer, S, Sundberg, JP and Ghim, S. Human Papillomavirus and Skin Cancer. J Invest Dermatol Symp Proc. Dec;6(3):203-6, 2001. 133. Ghim, S, Delgado, G, Sundberg, JP, and Jenson, AB. The pathogenesis of advanced cervical cancer provides the basis for an emperical therapeutic vaccine. J. Exptl. Molec. Pathol 71(3):181-185, 2001. 134. Ghim, S, Basu, PS, and Jenson, AB. Cervical cancer, etiology, pathogenesis treatment and future vaccines. Asian Pacific Journal of Cancer Prevention (3), 207-214, 2002. 135. Wlazlo, AP, Sparkowski, JJ, Jenson, AB, Schlegel, R Expression of the bovine papillomavirus type 1 E5B gene reveals a protein-protein interaction of the E5A and E5B gene products. Virology 307(2):396-405, 2003. 136. Ghim, Shin-je, Rector, A, Delius, H, Sundberg, J. Jenson, AB, and van Ranst, M. Equine Papillomavirus type 1: complete nucleotide sequence and characterization of recombinant

16 Alfred Bennett Jenson, M.D. Curriculum Vitae

virus-like particles composed of the EcPV-L1 major capsid protein. BioChemical and BioPhysical Res. Comm 324, 1108-1115, 2004. 137 Rector, A, Bossart, GD, Ghim, S-J, Sundberg, JP, Jenson, AB, and van Ranst, M. Characterization of a novel close-to-root papillomavirus from a Florida manatee by using multiple primed rolling-circle amplification:Trichechus manatus latirostris Papillomavirus type 1. J Virol.12, 698-702, 2004. 138. Bossart, GD, Ghim S-J, Rehtanz, M, Goldstein, J, Varela, R, Ewing, RY, Fair, PA, Lenzi, R, Joseph, B, Hicks, CL, Schneider, LS, McKinnie, CJ, Reif, JS, Sanchez, R, Lopez A, Novoa, S., Bernal J, Goretti, M, Goretti, M, Rodriquez, M, Defran, RH, and Jenson, AB. Orogenital Neoplasia in Atlantic Bottlenose Dolpins (Tursiops truncates). Aquatic Mammals 32 (4), 473-480, 2005. 139. Rehtanz, M, Ghim, S., Rector A, Van Ranst M, Fair, PA, Bossart, GD, and Jenson, AB. Isolation and characterization of he first American Bottlenose Dolphin papillomavirus; Tursiops truncus Papillomavirus Type 2: TtPV2; J. General Virology 3559-65, 2006. 140. Hang Y, Ghim S-J, Newsome J, Apolinario Olcese, T V, Martin M, Delius H, Felsburg, Jenson, AB, and R. Schlegel. An epidermotropic canine Papillomavirus with malignant potential contains an E5 gene and establishes a unique genus. Virology, 2006 epub. 141. Dooerslaer, KV, Rector, A, Jenson, AB, Sundbeg, JP, Van Ranst, M and Ghim, S-J. Complete genomic characterization murine papillomavirus isolated from papillomatous lesions from European harvest mice (Micromys minutus, MmPV). J General Virology 88;1484-8 2007, 142. Majka M, Drukala J, Lesko E, Wysoczynski M, Jenson AB, Ratajczak MZ. SDF-1 alone and in co-operation with HGF regulates biology of human cervical carcinoma cells. Folia Histochem Cytobiol. 2006;44(3):155-64. 143. Rector A. Lemey, P, Tachezy, R, Mostmans S, Ghim S, Doorslaer, KV, Roelke, M, Bush, M. Montali, RJ, Burk RD, Jenson, AB, Sundberg, J, Sapiro B, and M van Ranst. Ancient papillomavirus-host co-speciation in Felidae. Genome Biology 8; 2007. 144. Garbett, NC, Miller, J, Jenson, AB and Chaires JB. Calorimetric analysis of the plasma proteome. Semin Nephrol. 6: 621-6, 2007. 145. Garbett, NC, Miller, J, Jenson, AB and Chaires JB. Interrogation of the plasma proteome with differential scanning calorimetry. Clin Chem. 11:2012-4, 2007. 146. Garbett NC, Miller JJ, Jenson AB, Chaires JB. Calorimetry outside the box: a new window into the plasma proteome. Biophys J. 94(4):1377-83, 2008. 147. Rector A, Stevens H, Lacave G, Lemey P, Mostmans S, Salbany A, Vos M, Van Doorslaer K, Ghim SJ, Rehtanz M, Bossart GD, Jenson AB, Van Ranst M. Genomic characterization of novel dolphin papillomaviruses provides indications for recombination within the Papillomavirida. Virology. 378(1):151-61, 2008. 148. Ghim S, Jenson AB, Bubier JA, Silva KA, Smith RS, Sundberg JP. Cataracts in transgenic mice caused by a human papillomavirus type 18 E7 oncogene driven by KRT1-14. Exp Mol Pathol. 85(2): 77-82, 2018. 149. Liu Y, Clem B, Zuba-Surma EK, El-Naggar S, Telang S, Jenson AB, Wang Y, Shao H,Ratajczak MZ, Chesney J, Dean DC. Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Stem Cell. 4(4):336- 47, 2009.

17 Alfred Bennett Jenson, M.D. Curriculum Vitae

150. Joh J, Hopper K, Van Doorslaer K, Sundberg JP, Jenson AB, Ghim SJ. Macaca fasciculari papillomavirus type 1: a non-human primate betapapillomavirus causing rapidly progressive hand and foot papillomatosis. J Gen Virol. 90(Pt 4):987-94, 2009. 151. Garbett NC, Mekmaysy CS, Helm CW, Jenson AB, Chaires JB. Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring. Exp Mol Pathol. 86(3):186-91, 2009.

152. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G. The role of human papilloma virus in lung cancer: a review of the evidence. Am J Med Sci. 338(1):64-7, 2009. 153. Palmer KE, Jenson AB, Kouokam JC, Lasnik AB, Ghim SJ. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer. Exp Mol Pathol. 86(3):224-33, 2009. 154. Desai PC, Jaglal MV, Gopal P, Ghim SJ, Miller DM, Farghaly H, and Jenson AB. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study. Exp Mol Pathol. 87(2):94-8, 2009. 155. Munagala R, Donà MG, Rai SN, Jenson AB, Bala N, Ghim SJ, Gupta RC. Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response. Int J Oncol. 34(1): 263-71, 2009. 156. Rehtanz M, Bossart GD, Doescher B, Rector A, Van Ranst M, Fair PA, Jenson AB and Ghim SJ. Bottlenose dolphins (Tursiops truncates) papillomavirus. Vet Microbial. 133; 43-53, 2009. 157. Rehtanz, Ghim SJ, McFee W, Doescher B, Lacave G, Fair PA, Reif JS, Bossart GD and Jenson AB. Papillomavirus antibody prevalence in free-ranging and captive bottlenose dolphins (Tursips truncates). J Wildl Disease 46: 136-45, 2010. 158. Joh J, Jenson AB, Moore GD, Rezazedeh A, Slone SP, Ghim S and Kloecker GH. Human papillomavirus (HPV) and Merkel cell Polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol. 89; 222-6, 2010. 159. Joh J, Jenson AB, King WW, Proctor ML, Ingle A, Sundberg JP and Ghim SJ. Genomic analysis of the first laboratory mouse papillomavirus (MusPV). J. Gen Virol. 92:692-8, 2010. 160. Ingle A, Ghim S, Joh J, Chepkoech I, Jenson AB and Sundberg JP. Novel laboratory mouse papillomavirus (MusPV) infection. Vet Pathol. 48(2):500-5, 2011.

161. Donà MG, Rehtanz M, Adimey NM, Bossart GD, Jenson AB, Bonde RK, Ghim SJ. Seroepidemiology of TmPV1 infection in captive and wild Florida manatees (Trichechus manatus latirostris). J Wildl Dis. 47(3):673-84, 2011. 162. Wadsworth B, Bumpous JM, Martin AW, Nowacki MR, Jenson AB, Farghaly H. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV). Head Neck Pathol. 5(4):349-54, 2011. 163. Rehtanz M, Bossart GD, Fair PA, Reif JS, Ghim SJ, Jenson AB. Papillomaviruses and herpesviruses: who is who in genital tumor development of free-ranging Atlantic bottlenose dolphins (Tursiops truncatus)? Vet Microbiol. 160(3-4):297-304, 2012. 164. Joh J, Jenson AB, Proctor M, Ingle A, Silva KA, Potter CS, Sundberg JP, Ghim SJ. Molecular diagnosis of a laboratory mouse papillomavirus (MusPV). Exp Mol Pathol. 93(3):416-21, 2012.

18 Alfred Bennett Jenson, M.D. Curriculum Vitae

165. Moktar A, Ravoori S, Vadhanam MV, Pan J, Rai SN, Jenson AB, Parker LP, Gupta RC. Vaginal cells of smokers are more resistant to human papillomavirus infection than that of non-smoker. Exp Mol Pathol. 93(3):422-7, 2012. 166. Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, Dean DC. Sequential inductions of the Zeb1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression. J Biol Chem. 288(16):11572-80, 2013. 167. Storey R, Joh J, Kwon A, Jenson AB, Ghim SJ, Kloecker GH. Detection of immunoglobulin G against E7 of human papillomavirus in non-small-cell cancerJ Oncol. 2013:240164, 2013. 168. Joh J, Proctor ML, Ditslear JL, King WW, Sundberg JP, Jenson AB, Ghim SJ. Epidemiological and phylogenetic analysis of institutional mouse parvoviruses. Exp Mol Pathol. 95(1):32-7, 2013. 169. Liu Y, Sánchez-Tilló E, Lu X, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, Dean DC. Rb1 family mutation is sufficient for sarcoma Initiation. Nat Commun. 4:2650, 2013. 170. Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, Dean DC. The ZEB1 transcription factor in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmil expression. J Biol Chem. 14;289(7):4116-25, 2014. 171. Joh J, Jenson AB, Ingle A, Sundberg JP, Ghim SJ. Searching for the initiating site of the major capsid protein to generate virus-like particles for a novel laboratory mouse papillomavirus. Exp Mol Pathol. 96(2):155-61, 2014. 172. Garbett NC, Merchant ML, Helm CW, Jenson AB, Klein JB, Chaires JB. Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry. PLoS One. 8;9(1):e84710, 2014. 173. Sundberg JP, Stearns TM, Joh J, Proctor M, Ingle A, Silva KA, Dadras SS, Jenson AB, Ghim SJ. Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas. PLoS One. 9(12):e113582, 2014. 174. Khanal S, Joh J, Kwon AM, Zahin M, Perez CA, Dunlap NE, Silverman CL, Tennant PA, Potts KL, Kloecker GH, Bumpous JM, Ghim SJ, Jenson AB, Redman RA. Human papillomavirus E7 serology and association with p16. Pathol. 99(2):335-40, 2015. 175. Khanal S, Ferraris ED, Zahin M, Joh J, Ghim SJ, Jenson AB. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan- HPV vaccine development. Exp Mol Pathol. 99 (2):330-4, 2015. 176. Zahin M, Ghim SJ, Khanal S, Bossart GD, Jenson AB, Joh J. Molecular characterization of novel mucosotropic papillomaviruses from a Florida manatee (Trichechus manatus latirostris). J Gen Virol. 2015 Sep 21. [Epub ahead of print]. 177. Khanal S, Cole ET, Joh J, Ghim SJ, Jenson AB, Rai SN, Trainor PJ, Shumway BS. Human papillomavirus detection in histologic samples of multifocal epithelial hyperplasia: a novel demographic presentation. Oral Surg Oral Med Oral Pathol Oral Radiol. 120(6):733-43, 2015. 178. Dupre TV, Doll MA, Shah PP, Sharp CN, Kiefer A, Scherzer MT, Saurabh K, Saforo D, Siow D, Casson L, Arteel GE, Jenson AB, Megyesi J, Schnellmann RG, Beverly LJ,

19 Alfred Bennett Jenson, M.D. Curriculum Vitae

Siskind LJ. Suramin protects from cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol. 1;310, 2016. 179. Basu P, Jenson AB, Majhi T, Choudhury P, Mandal R, Banerjee D, Biswas J, Pan J, Rai SN, Ghim SJ, Miller D. Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage Stage III Cervical Carcinoma. Int J Radiation Oncol Biol Phys. 94(1):102-10, 2016. 180. Jenson AB, Ghim SJ, Sundberg JP. An Inquiry into the Causes and Effects of the Variolae Vaccinae (or Cow-Pox. 1798). Exp Dermatol. 2016 Jan 6. [Epub ahead of print]

RESEARCH GATE SCORE 45.17

INVITED PAPERS AND BOOK CHAPTERS (#45)

1. Rabin ER, and Jenson AB. Electron microscopic studies of animal viruses with emphasis on in vivo infections. Prog Med Virol 9:392-450, 1967. 2. Puga A, Jenson AB, Boaz J, Jensen FC, Kohne DE, and Lerner RA. Molecular analysis of a murine leukemia virus produced by continuously growing thymocytes. Prog Immunol II, 5:15-, l974. 3. Notkins AL, Yoon JW, Onodera T, and Jenson AB. Virus-induced diabetes mellitus: Infection of mice with variants of encephalomyocarditis virus, Coxsackievirus B4 and reovirus type 3. In Treatment of Early Diabetes, edited by RA Camerin-Davalos and B Hanover (Plenum Publishing Corp), pp 137-46, l979. 4. Jenson AB, Openshaw H, Hooks JL, Puga A, and Notkins AL. Herpes and other virally induced oral diseases. In Current Advances in Oral Biology, edited by HC Slavkin and DW Cohen (Dist Syst Inc; Bristol, Pa), Vol 1, no 3, pp. 1-45, 1979. 5. Jenson AB, and Dobersen MJ. Etiopathology of diabetes mellitus. Perspect Pediatr Pathol 7:167-84, 1982. 6. Jenson AB, Link CC, and Lancaster WD. Papillomavirus etiology of oral cavity papillomas. In Viral Infections in Oral Medicine. Ed. by J Hooks and W Jordan. (Elsevier North Holland), pp 133-46, l982. 7. Notkins AL, Yoon JW, Onodera T, Wheeler J, and Jenson AB. Slides on viruses and diabetes. Edited by AG Cudworth and M Bessler (Gower Med. Publishing, LTD, London, England). 8. Kurman RJ, Jenson AB, Sinclair C, and Lancaster WD. Detection of human papillomaviruses by immunocytochemistry. In Advances in Immunocytochemistry. ed. by RA DeLelis (New York:Masson), pp. 201-21, 1984. 9. Jenson AB and Rosenberg HS. Multiple viruses in diabetes mellitus. Prog Med Virol 29:197-17, l984. 10. Goes JS Jr, Lemos LB, Jenson AB, Lancaster WD, and Kurman RJ. Presence of papillomavirus antigens in premalignant lesions of uterine cervix in Brazil. Rev. Bras. Ginec. Obstet.:46, l983. 11. Jenson AB, Kurman RJ, Lancaster WD. Human papillomaviruses. In Textbook of Human Virology. ed.by R. Belshe (PSG, MASS), pp. 951-68, l984.

20 Alfred Bennett Jenson, M.D. Curriculum Vitae

12. Jenson AB, Kurman RJ, and Lancaster WD. Detection of papillomavirus common antigens in lesions of the skin and mucosa. Clinics Dermatol 3:56-63, l985. 13. Lancaster WD, Kurman RJ, and Jenson AB. Papillomaviruses in anogenital neoplasms. In Molecular Analysis and Diagnosis of Malignancy. Ed. by AA Luderer and HH Weetall. (Humana Press, Inc.) pp. 153-83, l986. 14. Lemos LB, and Jenson AB Pathology of Aspergillosis. Aspergillosis. ed. by GE Wagner and Y Al-Doory, (CC Thomas), pp. 156-95, l985. 15. Jenson AB, Lancaster WD, and Kurman RJ. Uterine Cervix. In The Pathology Of Incipient Neoplasia. Ed. by D. Henson and Albores-Saavedra (WB Saunders Co, Phil. PA), pp. 249-63, l986. 16. Jenson AB, Lim LY, and Lancaster WD. Role of papillomavirus in proliferative squamous lesions. Surv. Synth Pathol Res 4:8-13, l985. 17. Lorincz AT, Lancaster WD, Kurman RJ, Jenson AB, and Temple G. Characterization of human papillomaviruses in cervical neoplasias and their detection in routine clinical screening. In Viral Origins of Cervical Cancer. Banbury Report 21. Ed R Petro and H zur Hausen. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), pp. 225-37, l986. 18. Kurman RJ, Jenson AB, and Lancaster WD. Papillomaviruses and cervical neoplasia: Reflections on the past, perceptions of the present and speculations for the future. In Papillomaviruses: Molecular and Clinical Aspects. Eds. P Howley and T Broker (Alan R. Liss, Inc), pp. 3-18, l985. 19. Lancaster WD, and Jenson AB. Viruses in human cancer II. Papillomaviruses. Oncology Overview, April l987. 20. Johnson A, Hallman J, Alijani MR, Melhorn N, Lim LY, Jenson AB, and Helfrich GB. A prospective study of the clinical relevance of the current serum antiglobulin-augumented T- cell crossmatch in renal transplant recipients. Transpl Proc. X1X. 792-93, 1987. 21. Jenson AB and Rosenberg H. Pancreatic cell damage in children with fatal viral infections. IN Virus infections and Diabetes mellitus. Ed. Y. Becker.(Martinus Nijhoff Publishing, Boston, MASS), pp. 161-87, 1987. 22. Jenson AB, Kurman RJ, and Lancaster WD. HPV immunology appears promising. Contemporary OB. GYN. 28:59-65, 1986. 23. Jenson AB, Kurman RJ, and Lancaster WD. Tissue effects and host response to human papillomavirus infection. Obstet. Gynecol Clin North Am 14: 397-406, 1987. 24. Lancaster WD, and Jenson AB. Natural history of human papillomavirus infection of the anogenital tract. Cancer Metastasis Rev 6:653-64, 1987. 25. Jenson AB, and Lancaster WD. Association of human papillomavirus with benign, premalignant and malignant anogenital lesions. IN Papillomavirus and Human Cancer. ed. by H. Pfister (CRC Press, Inc.), 11-43, 1990. 26. Lancaster WD, and Jenson AB. Detection of human papillomavirus infection. IN Molecular Genetics in Cancer Diagnosis. Ed. J. Cossman (Elsevier, NY, Amsterdam, London), 331-48, 1990. 27. Jenson AB, Kurman RJ, and Lancaster WD. Tissue effects of and host response to human papillomavirus infection. Dermatol Clin 9:203-9, 1991. 28. Jenson AB. Human papillomavirus genotyping and serotyping. Introduction. In: Clinical Immunology Newsletter. Ed. AB Jenson. (Elsevier, NY, Amsterdam, London), Vol. 12, 97-112, 1992.

21 Alfred Bennett Jenson, M.D. Curriculum Vitae

29. Ghim S-J, Schlegel R, Hines J, Christensen N, Kreider J, and Jenson AB. Comparison of PV conformational epitopes expressed by L1 proteins in mammalian (cos) and insect (Sf9) cells. IN: Immunology of Human Papillomaviruses. Ed. MA Stanley (Plenum Press, New York),pp. 147-53, 1994. 30. Jenson AB and Geyer S. Introduction to “Overview of requirements for quality control and assurance in molecular diagnostics transferred to the clinical laboratory and the role of the FDA and USDA in licensing test Kits that make this possible”. In: Clinical Immunology Newsletter. Ed. AB Jenson. (Elsevier, NY, Amsterdam,London), Vol. 13(11), 137-52, 1993. 31. Geyer S and Jenson AB. Transferring molecular biology to the clinical laboratory. In: Clinical Immunology NewsLetter. Ed. AB Jenson (Elsevier, New, Amsterdam, London) Vol. 13(11):137-41, 1993. 32. Jenson AB. Los Respuesta inmune humoral a los VPH deteccion, tipificacion serologica de la vacuna. IN: Cancer Cervicouterino Y Lesiones Premalignas. Avances recientes en Epidemiologia diagnostico y tratamiento Bases inmunologicas y de Biologia Molecular. Ed. Cesar Santiago Pineda (ISBN), 76-84, 1993. 33. Jenson AB and Ghim SJ. Humoral and cell-mediated immune responses to human and animal papillomavirus infections. IN: Cancer Cervicouterina Y Lesionses Pemalignas. Advances recientes en Epidemiologica diagnostico y tratamiento Bases immunologicas y de Biologia Molecular. Ed. Cesar Santiago Pineda (ISABN), 1994. 34. Bittermann P, and JensonAB. In: Pathology of Incipicient Neoplasia. The Uterine Cervix. Monograph in the Series “Major Problems in Pathology.” Ed. V. A. Livolsi (W. B. Saunders Co, Philadelphia, London, Toronto, Montreal Syndney, Tokyo) Vol. 28, 248-67, 1993. 35. Sundberg JP, Schlegel R, and Jenson AB. Animal Model of Human Disease; Mucosotropic papillomavirus infections. Comp. Path. Bull. 28:4-6,1995. 36. Ghim SJ, Suzich JA, Tamura J, Bell JA, White W, Newsome J, Hill F, Warrener P, Sundberg J., Jenson AB, and Schlegel R. Formalin-inactivated oral papilloma extracts and recombinant L1 vaccines protect completely against mucosal papillomavirus infection: A canine model. Vaccines 95:375-79,1995. 38. Ferenczy A, and Jenson AB. Tissue effects and host response: The key to the rational triage of cervical neoplasia. Obst. Gynec. Clinics N. America 23:759-82, 1996. 39. Jenson, AB, Jenson MC, Cowsert L, Ghim SJ, and Sundberg John. Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant. Immunologic Research 16:115-19, 1997. 40. Hines JF, and Jenson AB. Human Papillomaviruses. IN Pathology of Infectious Diseases. D.H. Connor and F.W. Chandler Eds. (Appleton and Lang), pp. 199-208, 1997. 41. Schwartz D, Jenson AB, and Lim L. Corynebacterial infections. IN Pathology of Infectious Diseases. D.H. Connor and F.W. Chandler Eds (Appleton and Lang), pp. 533- 42, 1997. 42. Sundberg JP, Van Ranst M, Burk RB, and Jenson AB. The nonhuman (animal) papillomaviruses: host range, epitope conservation, and molecular diversity. IN Human Papillomavirus Infections in Dermatoveneroeology. G. Gross and G. Van Krogh Eds. (CRC Press, Inc.), 47-68, 1996. 43. Sundberg JP, Schlegel R, and Jenson AB. Mucosotropic papillomavirus infections.

22 Alfred Bennett Jenson, M.D. Curriculum Vitae

Lab Animal Science 48:240-242, 1998. 44. Sundberg JP, Ghim SJ, Van Ranst M, and Jenson AB. Nonhuman papillomaviruses: host range, pathology, epitope conservation, and new vaccine approaches. In: Spontaneous Animal Tumors: a survey. Rossi, L, Richardson, R, and Haarshbarger, J (eds), Press Point d Abbiategraso, Milano, pp. 33-40, 1997. 45. Joslin JO, Garner M Collins D, Kamaka E, Sinabaldi K, Meleo K, Montali R, Sundberg JP,Jenson AB, Ghim SH, Davidow B Hargis AM, West K, Clark T, Haines D: Viral Papilloma and squamous cell carcinomas in snow leopards (Uncia uncia). ProcAAZV/IAAAM Conf 2000, 155-158.

University of Louisville Medical School Contributions

>100,000 per year (Jenson and Ghim) 2013-2015